Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial
Simon Parlow(University of Ottawa), Rebecca Mathew(University of Ottawa), Melissa Fay Lepage-Ratte(University of Ottawa), Emilie P. Belley‐Côté(McMaster University), Jeffrey A. Marbach(Tufts Medical Center), Z. Koopman(University of Ottawa), Laura Goodliffe(McMaster University), Lee H. Sterling(University of Ottawa), Richard G. Jung(University of Ottawa), Graeme Prosperi‐Porta(University of Ottawa), Faizan Amin(McMaster University), Hannah Feagan(University of Ottawa), Shannon M. Fernando(University of Ottawa), Pouya Motazedian(University of Ottawa), Baylie Morgan(University of Ottawa), Kwadwo Kyeremanteng(University of Ottawa), Lisa Robinson(West Virginia University), Pietro Di Santo(University of Ottawa), Trevor Simard(University of Ottawa), Marino Labinaz(University of Ottawa), Benjamin Hibbert(Mayo Clinic), George A. Wells(University of Ottawa), Craig Ainsworth(McMaster University)
Cited by 17
Related Papers
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
|Intensive Care Medicine|2021|5.1k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
|Critical Care Medicine|2021|2.8k
Frailty in Older Adults Undergoing Aortic Valve Replacement
|Journal of the American College of Cardiology|2017|785
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
|New England Journal of Medicine|2021|711